Vutuc Christian, Waldhoer Thomas, Sevelda Paul, Micksche Michael, Haidinger Gerald
Department of Epidemiology, Centre of Public Health, Medical University of Vienna, Vienna, Austria.
J Med Screen. 2006;13(3):148-51. doi: 10.1258/096914106778440680.
The prevalence of self-reported participation and frequency of prostate cancer screening (digital rectal examination (DRE), prostate-specific antigen (PSA)) in Austrian men aged 40-79 years in the year 2005 is reported.
In a population-based cross-sectional study, a representative sample of 500 men was asked whether they ever had heard of early detection of prostate cancer by DRE or PSA test and, if so, whether they had ever had a prostate cancer screening test during their life, and if so the number of tests and the type of physician.
Overall, the prevalence of self-reported prostate cancer screening was 55.8% (23.7% DRE only). The highest prevalence was observed in the age group of 60-69 years with 68.8% (28.1% DRE only). The highest prevalence of PSA tests was observed in the age group 70-79 years (40.9%). About 75% of the screening tests were performed by urologists.
More than half of the target population (men aged 40-79 years) have had at least one prostate cancer screening test. Nearly one-third of men have already had one or more PSA tests. One-fifth of the PSA tests were requested by general practitioners or internists.
报告2005年奥地利40 - 79岁男性自我报告的参与前列腺癌筛查（直肠指检（DRE）、前列腺特异性抗原（PSA））的患病率及筛查频率。
在一项基于人群的横断面研究中，对500名男性代表样本询问他们是否听说过通过直肠指检或PSA检测进行前列腺癌早期检测，如果听说过，他们一生中是否进行过前列腺癌筛查检测，如果进行过，检测次数及医生类型。
总体而言，自我报告的前列腺癌筛查患病率为55.8%（仅直肠指检为23.7%）。60 - 69岁年龄组患病率最高，为68.8%（仅直肠指检为28.1%）。PSA检测患病率最高的年龄组为70 - 79岁（40.9%）。约75%的筛查检测由泌尿科医生进行。
超过一半的目标人群（40 - 79岁男性）至少进行过一次前列腺癌筛查检测。近三分之一的男性已经进行过一次或多次PSA检测。五分之一的PSA检测是由全科医生或内科医生要求进行的。
